Chiang, A., Loblaw, A., Jethava, V., Sethukavalan, P., Zhang, L., Vesprini, D., Mamedov, A., Nam, R. and Klotz, L. 2013. Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer. Canadian Urological Association Journal. 7, 11-12 (Dec. 2013), 450–3. DOI:https://doi.org/10.5489/cuaj.262.